Published in AIDS Weekly, January 1st, 2007
If the good results are borne out by further studies, "MK-0518 should clearly be a welcome addition to the existing treatment options for those persons infected with HIV-1," concludes the new study, led by Dr. Martin Markowitz of The Rockefeller University, New York.
Thirty-five previously untreated patients with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.